Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 413)
Posted On: 05/11/2021 10:33:22 AM
Post# of 36566
Posted By: Buildit
Re: Assiduous #29182
I believe they said on the call that each patient would bring in $115/mo. So if this practice has 500 patients that could be enrolled (stab in the dark), that would be $690k in annual revenues.

At some point, I thought it was said that the revenue split would be 50/50 w WWDC. Maybe I'm wrong here, but let's use that for discussion purposes.

So that's $345k in annual revs for NGH. At 70% EBITDA, that's approximately $250k in cash flow.

Seems paltry. But this is a small example. If they keep adding practices of this size and larger, it becomes significant.

If we reach Sunjay's 3500-5000 ST count, that's a margin contribution of $1.7MM-$2.4MM/yr. And that is largely a recurring revenue stream that can be added to.

If they gain a reputation in the industry, 3500-5000 could become a much larger number in a hurry.













(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site